市场调查报告书
商品编码
1519453
2024-2032 年按服务、治疗、应用和地区分類的医疗器材外包市场报告Medical Device Outsourcing Market Report by Service, Therapeutics, Application, and Region 2024-2032 |
IMARC Group年,全球医疗器材外包市场规模达到1,262亿美元。降低整体医疗成本的需求不断增长、严格的监管要求和品质标准的实施、可穿戴医疗设备的广泛采用以及个人化医疗需求的激增是推动市场成长的关键因素。
医疗器材外包是指与外部公司或服务提供者签订合约或合作以处理医疗器材产品生命週期各个方面的做法。这些外部合作伙伴通常是专业合约製造商、设计和开发公司、监管顾问、物流提供者或其他在医疗器材行业拥有专业知识的服务提供者。这些服务为公司带来了多种好处,包括节省成本、获得专业知识、提高营运效率以及更有效地适应市场需求的能力。它还允许医疗设备製造商专注于核心竞争力,例如研发、行销和策略规划,同时利用外部合作伙伴的能力来处理产品生命週期的其他重要方面。
由于医疗疾病的日益普及以及对优质医疗服务的需求不断增加,该市场正在经历显着增长。此外,外包也为医疗器材公司提供了根据市场需求扩大生产规模的灵活性。这种适应性对于管理产品需求的波动至关重要,特别是对于具有季节性变化或响应意外市场变化的设备。此外,个人化医疗需求的激增、穿戴式医疗设备的广泛采用、微创外科手术的日益普及以及家庭医疗保健、远距医疗和医疗旅游的兴起是推动市场的其他因素。此外,拥有国际业务的合约製造商可以提供进入多元化市场的机会并遵守进出口法规,促进更顺利地扩展到新地区并影响市场成长。
降低整体医疗费用的需求不断增长
医疗设备外包为医疗保健提供者和医疗设备公司节省了成本。与专业製造商或服务提供者签订合约比维持内部营运更具成本效益。外部合作伙伴已经建立了生产设施、规模经济和简化的流程,使他们能够以更低的成本生产医疗器材。此外,外包非核心活动,例如製造和物流,可以使医疗器材公司优化资源配置。透过将日常任务委託给外部合作伙伴,公司可以将内部资源集中在研究、开发和创新等核心能力上,从而生产出更具成本效益和竞争力的产品。
执行严格的监管要求和品质标准
严格法规的实施给医疗器材公司及其外包合作伙伴带来了更高的合规负担。合约製造商必须遵守与原始设备製造商相同的监管标准,以确保他们生产的医疗器材符合所需的安全和品质基准。这需要严格的文件记录、品质管理系统并遵守良好生产规范 (GMP)。此外,随着监管审查越来越严格,品质保证在医疗器材外包过程中变得至关重要。合约製造商现在面临着实施强有力的品质控制措施和风险管理策略的压力,以识别和减轻生产过程中的潜在问题。
穿戴式医疗设备的广泛采用
穿戴式医疗设备通常包含先进的感测器、无线连接和复杂的资料分析功能。此类技术密集型设备的开发和製造需要专门的专业知识和资源,从而导致对具有先进电子和软体开发专业知识的外包合作伙伴的需求增加。此外,医疗设备需要轻巧、舒适且符合人体工学设计,以确保使用者的合规性和长期配戴性。拥有小型化技术和材料选择专业知识的合约製造商在实现这些设计要求方面发挥着至关重要的作用。
The global medical device outsourcing market size reached US$ 126.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 258.2 Billion by 2032, exhibiting a growth rate (CAGR) of 8.1% during 2024-2032. The rising need to reduce overall medical costs, the implementation of stringent regulatory requirements and quality standards, the expanding adoption of wearable medical devices, and the surging demand for personalized medicine are among the key factors driving the market growth.
Medical device outsourcing refers to the practice of contracting or partnering with external companies or service providers to handle various aspects of the medical device product lifecycle. These external partners are typically specialized contract manufacturers, design and development firms, regulatory consultants, logistics providers, or other service providers with expertise in the medical device industry. These services offer several benefits to companies, including cost savings, access to specialized expertise, increased operational efficiency, and the ability to adapt to market demands more effectively. It also allows medical device manufacturers to concentrate on core competencies, such as research and development, marketing, and strategic planning, while leveraging the capabilities of external partners to handle other essential aspects of the product lifecycle.
The market is experiencing significant growth due to the increasing prevalence of medical ailments and the surging need for quality healthcare services. In addition, outsourcing offers medical device companies the flexibility to scale production volumes based on market demand. This adaptability is essential for managing fluctuations in product demand, especially for devices with seasonal variations or in response to unexpected market shifts. Moreover, the surging demand for personalized medicine, the expanding adoption of wearable medical devices, the growing popularity of minimally invasive surgical procedures, and the rising trend of home healthcare, telemedicine, and medical tourism are some of the other factors propelling the market. Besides, contract manufacturers with international operations can provide access to diverse markets and navigate import/export regulations, facilitating a smoother expansion into new regions and influencing the market growth.
The rising need to reduce overall medical costs
Medical device outsourcing offers cost savings to healthcare providers and medical device companies. Contracting with specialized manufacturers or service providers is more cost-efficient than maintaining in-house operations. External partners have established production facilities, economies of scale, and streamlined processes, enabling them to produce medical devices at lower costs. Moreover, outsourcing non-core activities, such as manufacturing and logistics, allows medical device companies to optimize resource allocation. By delegating routine tasks to external partners, companies can focus their internal resources on core competencies like research, development, and innovation, which can lead to more cost-effective and competitive products.
The implementation of stringent regulatory requirements and quality standards
The implementation of stringent regulations places a higher compliance burden on both medical device companies and their outsourcing partners. Contract manufacturers must adhere to the same regulatory standards as the OEMs to ensure that the medical devices they produce meet the required safety and quality benchmarks. This requires rigorous documentation, quality management systems, and adherence to good manufacturing practices (GMP). Moreover, with higher regulatory scrutiny, quality assurance becomes paramount in the medical device outsourcing process. Contract manufacturers are now under pressure to implement robust quality control measures and risk management strategies to identify and mitigate potential issues in the production process.
The expanding adoption of wearable medical devices
Wearable medical devices often incorporate advanced sensors, wireless connectivity, and sophisticated data analytics capabilities. The development and manufacturing of such technology-intensive devices require specialized expertise and resources, leading to an increased demand for outsourcing partners with expertise in advanced electronics and software development. Moreover, medical devices need to be lightweight, comfortable, and ergonomically designed to ensure user compliance and long-term wearability. Contract manufacturers with expertise in miniaturization techniques and materials selection play a crucial role in achieving these design requirements.
IMARC Group provides an analysis of the key trends in each segment of the global medical device outsourcing market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on service, therapeutics and application.
Regulatory Consulting
Product Design and Development
Product Testing and Sterilization
Product Implementation
Product Upgrade
Product Maintenance
Product design and development represent the leading segment
The report has provided a detailed breakup and analysis of the market based on the service. This includes regulatory consulting, product design and development, product testing and sterilization, product implementation, product upgrade, and product maintenance. According to the report, product design and development represented the largest segment.
Medical device design and development requires a high level of technical expertise, including knowledge of regulatory requirements, engineering principles, and medical standards. Many medical device companies lack in-house capabilities or resources to handle the complex design process efficiently. Outsourcing product design and development allows them to tap into the specialized expertise of experienced design firms and engineering companies with a proven track record in the medical device industry. Moreover, outsourcing product design and development enables medical device companies to access fresh ideas, creative solutions, and cutting-edge technologies from external design partners.
Cardiology
Diagnostic Imaging
Orthopedic
IVD
Ophthalmic
General and Plastic Surgery
Drug Delivery
Dental
Endoscopy
Diabetes Care
Cardiology exhibits a clear dominance in the market
A detailed breakup and analysis of the market based on therapeutics have also been provided in the report. This includes cardiology, diagnostic imaging, orthopedic, IVD, ophthalmic, general and plastic surgery, drug delivery, dental, endoscopy, and diabetes care. According to the report, cardiology accounted for the largest market share.
Cardiovascular diseases (CVDs) remain one of the leading causes of death worldwide. The increasing prevalence of conditions such as coronary artery disease, heart failure, and arrhythmias has led to a rising demand for innovative medical devices and technologies to diagnose, treat, and manage these conditions. This high demand has driven medical device companies to focus extensively on cardiology-related products and services, leading to a dominant presence in the outsourcing market. Besides, the field of cardiology has witnessed rapid technological advancements and continuous innovation. These innovations include implantable devices such as pacemakers, defibrillators, stents, and heart valves, as well as diagnostic devices like electrocardiograms (ECGs) and cardiac imaging equipment. To keep up with the pace of innovation and meet market demands, medical device companies often seek specialized outsourcing partners with expertise in cardiology product development.
Class I
Class II
Class III
Class II accounts for the majority of the market share
The report has provided a detailed breakup and analysis of the market based on the application. This includes class I, II, and III. According to the report, class II represented the largest segment.
Class II medical devices encompass a wide range of products, including moderate to high-risk devices that do not fall into the highest-risk Class III category. This broad product range includes items such as infusion pumps, diagnostic imaging equipment, electrocardiographs, surgical instruments, and certain implantable devices. The diversity of Class II devices contributes to a larger market share in the outsourcing industry. Moreover, these medical devices are subject to intermediate levels of regulatory scrutiny compared to Class III devices. While Class II devices must still meet strict regulatory requirements for safety and efficacy, the regulatory process is generally less burdensome and time-consuming than that for Class III devices, which is escalating their demand.
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Asia Pacific exhibits a clear dominance, accounting for the largest medical device outsourcing market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Latin America (Mexico, Brazil, Others); Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others); and Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others). According to the report, Asia Pacific was the largest market for medical device outsourcing.
Asia Pacific countries, such as China, India, and Southeast Asian nations, offer a significant cost advantage in terms of labor and manufacturing. The lower labor costs, combined with well-developed manufacturing infrastructure and supply chain networks, make the region an attractive option for medical device companies seeking cost-effective outsourcing solutions. Moreover, the region boasts a large pool of skilled and trained professionals in engineering, science, and technology fields. This skilled workforce includes engineers, scientists, and technicians with expertise in medical device design, development, and manufacturing. The availability of such talent accelerates the outsourcing process and ensures high-quality products.
The competitive landscape of the medical device outsourcing market is highly dynamic with numerous companies offering a wide range of outsourcing services to medical device manufacturers. Nowadays, key players are expanding their service portfolios to provide a comprehensive range of outsourcing solutions. They are diversifying their offerings to include contract manufacturing, product design and development, regulatory support, post-market services, packaging, and logistics. Companies are also engaging in mergers, acquisitions, and strategic partnerships to expand their geographical presence and technical capabilities. They are also investing heavily in advanced manufacturing technologies such as automation, robotics, 3D printing, and data analytics to improve production efficiency, reduce costs, and offer faster turnaround times to medical device manufacturers.
Celestica Inc. (Onex Corporation)
Charles River Laboratories International Inc.
Flex Ltd.
Freyr Inc.
Heraeus Holding GmbH
ICON plc
Integer Holdings Corporation
IQVIA Inc.
Plexus Corp.
Sanmina Corporation
TE Connectivity
West Pharmaceutical Services Inc.
Flex Ltd. launched "Healthcare Solutions," a comprehensive suite of medical device design, engineering, and manufacturing services. The offering includes rapid prototyping, miniaturization expertise, and end-to-end solutions to support medical device companies throughout the product lifecycle.
Celestica acquired PCI Limited, a provider of design and manufacturing services for medical and other industries. This acquisition strengthened Celestica's presence in the medical device outsourcing market and expanded its offerings in the Asia Pacific region.
Celestica Inc. acquired Atrenne Integrated Solutions, a provider of electronic manufacturing and design services for the aerospace, defense, and other industries. This acquisition enhanced Celestica's capabilities in serving the medical device market.